- Approval Id
- 6db61e17c8aca0a3
- Drug Name
- BETNOVATE SCALP APPLICATION 0.1% w/w
- Product Name
- BETNOVATE SCALP APPLICATION 0.1% w/w
- Approval Number
- SIN07714P
- Approval Date
- 1994-05-05
- Registrant
- GLAXOSMITHKLINE PTE LTD
- Licence Holder
- GLAXOSMITHKLINE PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- SOLUTION
- Dosage
- **DOSAGE AND ADMINISTRATION**
A small quantity of Betnovate Scalp Application should be applied to the scalp night and morning until improvement is noticeable. It may then be possible to sustain improvement by applying once a day, or less frequently.
- Route Of Administration
- TOPICAL
- Indication Info
- **INDICATIONS**
Steroid responsive dermatoses of the scalp such as psoriasis, seborrhoea capitis, inflammation associated with severe dandruff.
- Contraindications
- **CONTRA-INDICATIONS**
Infections of the scalp.
Hypersensitivity to the preparation.
Use is not indicated in dermatoses in children under one year of age, including dermatitis.
- Atc Code
- D07AC01
- Atc Item Name
- betamethasone
- Pharma Manufacturer Name
- GLAXOSMITHKLINE PTE LTD
- Company Detail Path
- /organization/glaxosmithkline-pte-ltd
